UPDATE 1-AstraZeneca a bid target again? CEO says someone may spot value

LONDON, July 28 (Reuters) - AstraZeneca's chief executive believes a rival could spot the growing value of its drug pipeline but declined to say if the group was likely to be a takeover target once more, two years after seeing off a bid from Pfizer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.